Mental Health

Health Tech Newsletter Mohana Ravindranath

STAT Plus: Health care AI investment hype, and value-based-care model for mental health apps

Health tech Mario Aguilar

STAT Plus: Highmark reboots coverage of digital treatments, raising hope among DTx companies

Health Lev Facher

STAT Plus: Biden administration finalizes rules to ensure insurers pay for mental health care 

First Opinion Mary Giliberti

Presidential debate moderators should ask about mental health policy

Health Timmy Broderick

Depression: How brain scans helped predict long-term treatment outcomes

Biotech Adam Feuerstein

STAT Plus: Neurocrine reports mixed results on schizophrenia therapy in mid-stage trial

Health Angus Chen

Study exposes the dangerous ‘hidden’ mental burden of cancer on patients’ spouses

Exclusive Meghana Keshavan

STAT Plus: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy

Health Nicholas St. Fleur

The story of the giraffe, its neck, and a possible treatment for human heart disease

Biotech Meghana Keshavan

STAT Plus: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy

Health tech Mario Aguilar

STAT Plus: Otsuka prices depression digital therapeutic to make it widely accessible, says it’ll lose money

Health Meghana Keshavan

STAT Plus: Three MDMA therapy papers retracted over ethics violations

First Opinion Susannah Baruch

Getting to ‘Plan B’ for psychedelic medicine: Lessons from reproductive health

Health Olivia Goldhill and Meghana Keshavan

STAT Plus: FDA rejects MDMA as a psychedelic treatment for PTSD

Health Meghana Keshavan and Olivia Goldhill

MDMA therapy is facing an imminent FDA decision. Here’s what you need to know

Health tech Mario Aguilar

STAT Plus: Big Health gets FDA nod for its digital therapy for insomnia

Morning Rounds Theresa Gaffney

Morning Rounds: The ‘very risky business’ of buying weight loss drugs online

Letters to the editor Patrick Skerrett

Letters on Sonya Massey’s death, vaccine injuries, and much more

First Opinion Onyeka T. Otugo and Adaira I. Landry

Sonya Massey’s death: How to prevent more killings of defenseless Black women

First Opinion Thomas R. Insel

Adding psychotherapy to drug therapy works, but the FDA may not be able to handle it

First Opinion David Tuller, Mady Hornig, and David Putrino

Functional neurological disorder is not an appropriate diagnosis for people with long Covid

Health Sarah Owermohle

STAT Plus: Elmo and his friends are helping little kids (and grown-ups) with their ‘big feelings’ amid a mental health crisis

A STAT Investigation Tara Bannow

STAT Plus: Troubled for-profit chains are stealthily operating dozens of psychiatric hospitals under nonprofits’ names

First Opinion Richard G. Frank

Psychiatrists aren’t fulfilling the social contract that subsidized their training

Politics Olivia Goldhill

STAT Plus: Don’t write off MDMA yet: How the FDA got on board with psychedelics

First Opinion Andrew D. Forsyth, Mallory O. Johnson, and Jae M. Sevelius

Turning a ‘no’ vote into progress: How to advance MDMA-assisted psychotherapy for PTSD

In the Lab Mohana Ravindranath

STAT Plus: Oral ketamine tablets effective for treating depression, new study finds

First Opinion Roshni Koli and Christine Yu Moutier

To reduce suicide, primary care and mental health clinicians need to work together. Congress can help that happen

Health Timmy Broderick

Supreme Court outlawed segregation of disabled people 25 years ago. But change has come slowly